← back to search

Till S. Clauditz

Universität Hamburg · DE
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Neuroendocrine Tumor Research Advances, and Cancer, Hypoxia, and Metabolism.
h-index
35
citations
4,509
works
322
NIH funding
primary concept
Medicine
email

Recent publications

Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.
2025cited by 6position: contributordoi
Discordance Between p16-Expression and HPV-Status in Sinonasal Carcinoma: A Multicenter Retrospective Study.
2025cited by 1position: contributordoi
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.
2025cited by 1position: contributordoi
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.
2025cited by 0position: contributordoi
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2024cited by 13position: middledoi
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors.
2024cited by 13position: contributordoi
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors.
2024cited by 8position: contributordoi
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities.
2024cited by 6position: contributordoi
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors.
2024cited by 5position: contributordoi
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors.
2024cited by 3position: contributordoi
Time is Gut. Approaching Intestinal Leiomyositis: Case Presentation and Literature Review.
2024cited by 1position: contributordoi
Automated <scp>Ki</scp>‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry
The Journal of Pathology 2023cited by 32position: middledoi
BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
Molecular Cancer Research 2023cited by 11position: middledoi
Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland.
2023cited by 11position: contributordoi
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial Orchestration.
2023cited by 9position: contributordoi
Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues.
2023cited by 3position: contributordoi
Lipidome Analysis of Oropharyngeal Tumor Tissues Using Nanosecond Infrared Laser (NIRL) Tissue Sampling and Subsequent Mass Spectrometry.
2023cited by 3position: contributordoi
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.
2023cited by 2position: contributordoi
Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer
Cancers 2022cited by 7position: middledoi
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors.
2022cited by 7position: contributordoi
Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer.
2022cited by 6position: contributordoi
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors.
2022cited by 6position: contributordoi
The Length of the Transition Zone in Patients with Rectosigmoid Hirschsprung Disease.
2022cited by 4position: contributordoi
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
2022cited by 3position: contributordoi
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Cellular Oncology 2021cited by 71position: middledoi
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.
2021cited by 70position: contributordoi
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
Cells 2021cited by 21position: middledoi
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.
2021cited by 18position: contributordoi
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours.
2021cited by 9position: contributordoi
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans
Blood 2020cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 20 papers (2021–2025)Ronald Simon · Universität Hamburg18 papers (2021–2025) · 16 papers (2021–2025)Maximilian Lennartz · Universität Hamburg14 papers (2021–2025)Claudia Hube-Magg · Universität Hamburg10 papers (2021–2025)Patrick Lebok · Universität Hamburg8 papers (2021–2025)Davin Dum · Universität Hamburg6 papers (2024–2025)Andreas M. Luebke · Universität Hamburg6 papers (2022–2024)Guido Sauter · Collaborative Group (United States)6 papers (2022–2025)Christian Bernreuther · Universität Hamburg5 papers (2022–2025)Ahmed Abdulwahab Bawahab · University of Jeddah4 papers (2024–2025) · 4 papers (2022–2025)Natalia Gorbokon · 4 papers (2024–2025)Christoph Fraune · Universität Hamburg3 papers (2022–2023)C. Betz · Universität Hamburg3 papers (2022–2025)Christian Bernreuther · National University of Singapore2 papers (2023–2024)Morton Freytag · Universität Hamburg2 papers (2025–2025) · 2 papers (2023–2024)Eik Vettorazzi · Universität Hamburg2 papers (2023–2023)Eike Burandt · UPMC Hillman Cancer Center2 papers (2023–2024)